REFERENCES
- Dixon DO, Neilan B, Jones SE, et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295–305.
- Vose JM, Armitage JO, Weisenburger DD, et al. The impor-tance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 1838–44.
- Greil R. Prognosis and management strategies of lymphatic neoplasias in the elderly, I: Aggressive non-Hodgkin's lympho-mas. Oncology 1998; 55: 189–217.
- Celsing F, Widell S, Merk K, et al. Addition of Etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma. Ann Oncol 1998; 9: 1213–7.
- Bertini M, Boccomini C, Calvi R. The influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL). Clin Lymphoma 2001; 4: 278–84.
- Osby E, Hagberg H, Kvalöy S, et al. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 2003; 101: 3840–8.
- Guinee VF, Björkholm M, Monfardini S. Hodgkin's disease in the elderly. In: Mauch PM, Armitage JO, Diehl V et al, eds. Hodgkin's disease. Philadelphia: Lippincott Williams & Wilk-ins; 1999. p. 713–35.
- Glasser M. Is longevity inherited? J Chronic Dis 1981; 34:439–44.
- Hammond EC, Garfinkel L, Seidman H. Longevity of parents and grandparents in relation to coronary heart disease and associated variables. Circulation 1971; 43: 31–44.
- Brand FN, Kiely DK, Kannel WB, Myers RH. Family patterns of coronary heart disease mortality: the Framingham Long-evity Study. J Clin Epidemiol 1992; 45: 169–74.
- Björkholm M, Wedelin C, Holm G. Familial longevity and prognosis in Hodgkin's disease. Cancer 1984; 54: 1088–92.
- Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988; 6: 292–3.
- World Health Organization. Handbook for reporting results of cancer treatment. Offset publication no. 48. Geneva, Switzer-land: WHO; 1979.
- Cosby E, Taube A, Cavallin-Stahl E, Hagberg H, Björkholm M. Reproducibility of tumour response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma. Med Oncol 2001; 18: 137–40.
- Kaplan HS, Meier P. Non-parametric estimation from incom-plete observation. Am Stat Assoc J 1958; 53: 457–80.
- Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: Analysis and examples. Br J Cancer 1977; 35: 1–39.
- Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187–220.
- Landgren 0, Askling J, Dickman P, et al. Parental longevity and survival in elderly patients with Hodgkin's disease. Haematologica 2002; 87: 595–601.
- Mitchell BD, Hsueh WC, King TM. Heritability of life span in the Old Order Omish. Am J Med Genet 2001; 102: 346–52.
- Olofsson P, Schwalb 0, Chakraborty R, Kimmel M. An application of a general branching process in the study of the genetics of aging. T Theor Biol 2001; 213: 547–57.
- Gudmundsson H, Gudbjartsson DF, Frigge M, Gulcher JR, Stefansson K. Inheritance of human longevity In Iceland. Eur J Hum Genet 2000; 8: 743–9.